Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 14, 2023, titled "Zydus receives final approval from the USFDA for Cyclophosphamide Capsules USP, 25 mg and 50 mg".
Press Release Dec 14 2023
Filed with NSE · · 2 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Dec 11 2023
- Press Release Dec 06 2023
- Press Release Dec 01 2023
- Press Release Nov 10 2023
- Press Release Nov 07 2023
Later from Zydus Lifesciences
- Press Release Dec 15 2023
- Press Release Dec 16 2023
- Press Release Dec 22 2023
- Press Release Jan 17 2024
- Zydus Lifesciences Limited Press Release Jan 19 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences